Global Pandemic Agreement Finalized, US Opts Out
In a significant development for global health governance, countries around the world have finalized a landmark agreement aimed at improving future pandemic preparedness and response. The culmination of over three years of intricate negotiations, the draft pandemic accord was agreed upon in Geneva in mid-April 2025. This historic step will see the document submitted for adoption at the 78th World Health Assembly, scheduled to commence on May 19. If approved by the Assembly, individual nations will then proceed with ratification [un.org](https://www.un.org/en/countries-finalize-historic-pandemic-agreement-after-three-years-negotiations).
The agreement explicitly states that it does not grant the World Health Organization (WHO) the authority to enforce health measures such as lockdowns, vaccination mandates, or border closures. This clarification appears designed to address concerns regarding national sovereignty and the scope of international health regulations. A notable absence from the final round of negotiations, however, was the United States, which had announced its intention to withdraw from the global health body in January and consequently would not be bound by the pact [news.un.org](https://news.un.org/en/story/2025/04/1162301) This decision by one of the world’s leading economies and a major contributor to global health initiatives adds a layer of complexity to the treaty’s universal application and impact.
Addressing Global Health Inequities
A primary driver behind the push for a new pandemic agreement was the stark inequity in access to essential medical supplies, particularly vaccines and treatments, observed during the COVID-19 pandemic. WHO Director-General Tedros Adhanom Ghebreyesus highlighted the “me first” approach adopted by wealthy nations, which secured vast quantities of vaccines, often leaving lower and middle-income countries with limited or no immediate access. The new treaty aims to establish basic frameworks for more equitable sharing of vaccines and drugs during future crises, a move seen as crucial for global health security.
Experts from institutions like the London School of Economics have frequently pointed out that the economic fallout from pandemics disproportionately affects developing nations, exacerbating existing global disparities. This agreement seeks to mitigate such impacts by formalizing mechanisms for technology transfer and local manufacturing capacity, particularly in the Global South. For instance, bolstering vaccine production capabilities in regions like Africa, as highlighted by WHO visits to facilities such as Biovac in South Africa, is a key objective of the new framework [science.org](https://www.science.org/content/article/global-pandemic-treaty-finalized-without-us-victory-multilateralism).
International Implications and Future Challenges
The finalization of this agreement, despite the U.S. non-participation, is being hailed in many international circles as a “victory for multilateralism.” It signifies a collective recognition by a majority of nations that global health threats necessitate a coordinated global response, transcending national borders. The treaty’s success, however, will ultimately depend on its ratification by individual countries and the subsequent political will to implement its provisions, especially concerning the equitable distribution of resources during a crisis.
The absence of the United States from this accord raises questions about the treaty’s universality and the potential for a bifurcated global response to future pandemics. While the U.S. may pursue its own pandemic preparedness strategies, the lack of its formal adherence to an internationally recognized framework could complicate global coordination efforts. The treaty’s provisions for information sharing, surveillance, and rapid response mechanisms are designed to be globally comprehensive, and the decision of a major power not to join will undoubtedly be a topic of discussion at the upcoming World Health Assembly.
As the world continues to grapple with emerging infectious diseases and the lessons learned from the COVID-19 crisis, this pandemic agreement represents a significant step towards creating a more resilient and equitable global health architecture. Its eventual impact will be measured by its ability to foster genuine international solidarity and concrete action when the next global health emergency inevitably strikes.
